Robert Arch, PhD (President) at Immunophotonics will be attending the ThinkEquity Conference at the Mandarin Oriental, New York on October 30th.

Robert will be presenting at 12:00 PM – 12:30 PM in the Lotus Suite West

Don’t miss his talk on how Immunophotonics’ innovative Interventional Immuno-Oncology® platform is redefining what’s possible in preventing tumor recurrence after local ablation therapy. Discover how our lead asset, IP-001, is tackling one of the most urgent challenges faced by cancer patients today.